Additional Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Neurological Observations
- Sponsor
- ElMindA Ltd
- Enrollment
- 55
- Locations
- 2
- Primary Endpoint
- engineering development according to clinical assessments
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The purpose of this study is to collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
Detailed Description
To collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™). The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System is cleared for use by qualified medical professionals for the post hoc statistical analysis of the human electroencephalogram ("EEG"), utilizing evoked response potentials ("ERP').
Investigators
Eligibility Criteria
Inclusion Criteria
- •Completed a BNA test in the past
- •Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments.
- •Willingness to participate
Exclusion Criteria
- •Significant Sensory deficit
Outcomes
Primary Outcomes
engineering development according to clinical assessments
Time Frame: 2 years
The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes.